Skip to main content
Fig. 2 | BMC Musculoskeletal Disorders

Fig. 2

From: Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs

Fig. 2

The mRNA expression of PPARγ2 and OGN in osteogenic or adipogenic differentiation of MMSCs and SMMSCs in vitro. a To investigate PPARγ2 and OGN in gene expression following differentiation, RT-qPCR was performed from 0 h to 14 days after induction of osteogenic differentiation in MMSCs and SMMSCs. b From 0 to 14 days after induction of adipogenic differentiation (PPARγ2 and OGN) in SMMSCs. c From 0 to 14 days after induction of adipogenic differentiation in MMSCs. Before differentiation (day 0) in SMMSCs served as controls as 1. Each assay was performed in three independent experiments. Data are expressed as mean ± SD from all experiments, as indicated * P < 0.05 and ** P < 0.01

Back to article page
\